Hamilton Thorne (HTLZF) Stock Price, News & Analysis

Company Overview

Hamilton Thorne Ltd. (OTCMKTS: HTLZF) is a life sciences instrumentation company specializing in laser and imaging solutions for assisted reproductive technology (ART) and cell biology markets. The company’s core product portfolio includes precision laser platforms for embryo biopsy and zona drilling, computer-assisted sperm analysis (CASA) systems for detailed semen evaluation, and high‐resolution imaging systems designed to support embryologists and research scientists in both clinical and laboratory settings.

Founded in the late 1990s and headquartered in Beverly, Massachusetts, with subsidiary operations in Canada, Hamilton Thorne has developed a global footprint serving fertility clinics, research institutions and contract laboratories in more than 80 countries. Its flagship offerings—such as the LaserShot® laser system, Oosight™ Imaging System and SpermVision® CASA platform—are engineered to improve the efficiency, reproducibility and safety of key ART procedures, including intracytoplasmic sperm injection (ICSI) and embryo screening.

Beyond product sales, Hamilton Thorne provides ongoing training, technical support and software updates to ensure end users maintain compliance with evolving regulatory standards and best practices in reproductive medicine. The company’s imaging software tools deliver quantitative cell analysis, empowering researchers to conduct advanced studies in areas such as stem cell research, gene editing and toxicology screening.

Led by a management team with deep expertise in biomedical engineering, reproductive biology and global sales, Hamilton Thorne continues to invest in research and development aimed at expanding its offerings and addressing emerging needs in fertility treatment and life sciences research. The company’s strategic focus remains on innovation, quality assurance and strengthening its international distribution network.

Key Stats

• Today's Range: $1.59 to $1.60
• 50-Day Range: $1.59 to $1.59
• 52-Week Range: $0.90 to $1.63
• Volume: 421,800 shs
• Average Volume: 29,614 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

HTLZF Stock Analysis - Frequently Asked Questions

How have HTLZF shares performed this year?

Hamilton Thorne's stock was trading at $1.5901 at the start of the year. Since then, HTLZF stock has increased by 0.0% and is now trading at $1.5901.

How do I buy shares of Hamilton Thorne?

Shares of HTLZF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 7/18/2025
• Next Earnings (Estimated): 8/12/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Medical Devices
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:HTLZF
• CIK: N/A
• Web: www.hamiltonthorne.ltd
• Phone: (978) 921-2050
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A